The Welsh Blood Service is stepping into the world of microfluidic research, thanks to a successful application to Welsh Government’s SMART Capital Equipment Fund.
The reviews aimed to provide as many answers as possible to patients, families and carers, as well as identifying opportunities for learning and improvement to enhance the quality and safety of care in NHS Wales.
Increasing the number of days offered at Nantgarw and extending the operating hours of each day will result in a 10% increase in the number of patients Velindre is able to treat with SACT each week.
The team behind the Nurse-led Post-radiotherapy Follow-up Clinic at the Cancer Centre has been shortlisted at this year's Nursing Times Awards.
The Welsh Blood Service is part of an innovation partnership looking at the potential for a drone-based delivery network.
The new roles have been specifically created in the areas of acute oncology (AOS) and systemic anti-cancer therapy (SACT) and will be based at Velindre Cancer Centre.
We're seeking an exceptional leader as our new Chief Executive Officer. The Trust is looking to appoint an inspirational, ambitious, highly experienced and successful leader to shape and deliver a high performing healthcare organisation.